Tri Locum Partners as of Dec. 31, 2025
Portfolio Holdings for Tri Locum Partners
Tri Locum Partners holds 15 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Johnson & Johnson (JNJ) | 16.2 | $125M | 603k | 206.95 | |
| Danaher Corporation (DHR) | 10.3 | $79M | 347k | 228.92 | |
| Eli Lilly & Co. (LLY) | 8.8 | $68M | 63k | 1074.68 | |
| United Therapeutics Corporation (UTHR) | 7.7 | $59M | 121k | 487.25 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 7.3 | $57M | 265k | 213.24 | |
| Madrigal Pharmaceuticals (MDGL) | 6.5 | $50M | 86k | 582.34 | |
| Boston Scientific Corporation (BSX) | 6.4 | $50M | 521k | 95.35 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 5.8 | $45M | 1.4M | 31.21 | |
| Ionis Pharmaceuticals (IONS) | 5.7 | $44M | 557k | 79.11 | |
| Vera Therapeutics Cl A (VERA) | 5.3 | $41M | 806k | 50.64 | |
| Axsome Therapeutics (AXSM) | 4.8 | $37M | 202k | 182.64 | |
| Argenx Se Sponsored Adr (ARGX) | 4.1 | $32M | 38k | 840.95 | |
| Nuvalent Inc-a (NUVL) | 4.0 | $31M | 307k | 100.59 | |
| Dex (DXCM) | 3.6 | $28M | 422k | 66.37 | |
| Dianthus Therapeutics (DNTH) | 3.3 | $26M | 622k | 41.21 |
